Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels-MedSci.cn

Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels

Lujan, JV; Lengerke-Diaz, PA; Jacobs, C; Moreno-Cortes, EF; Ramirez-Segura, CA; Choi, MY; McCarthy, C; Heinen, A; Kipps, TJ; Castro, JE

Castro, JE (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.

HAEMATOLOGICA, 2020; 105 (1): E22